surmount-osa trial tirzepatide results after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Tirzepatide for the Treatment of
Description
Figure 2 5 Clinical research progress and safety evaluation 5.1 Clinical efficacy studies Tirzepatide, a novel dual GLP-1 and GIP receptor agonist, has demonstrated remarkable efficacy in the management of type 2 diabetes and obesity, as evidenced by multiple high-quality clinical trials (43, 44)
Additionally, inadequate nutritional intake during treatment may contribute to fatigue
Now what
What storage and handling instructions should I follow at home
Table of Contents: How does Tirzepatide work to support weight management
Always pinch the skin to lift the subcutaneous tissue away from the muscle
